Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
3
×
boston blog main
3
×
clinical trials
3
×
fda
life sciences
national blog main
national top stories
new york blog main
new york top stories
novartis
3
×
alnylam pharmaceuticals
amgen
boston top stories
boulder/denver blog main
boulder/denver top stories
deals
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
sanofi
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
akouos
alder biopharmaceuticals
alirocumab
allergan
amag pharmaceuticals
What
medicines
3
×
deal
drug
fda
new
acquire
acquisitions
agreed
amgen
announced
approval
billion
bio
brings
candidates
cash
ceo
cholesterol
class
collabs
company
compound
covid
daniel
developed
gets
gilead
gilead’s
head
help
introduce
ipo
medco
migraine
month
nod
novartis
o’day
pain
plans
Language
unset
Current search:
biotech
×
novartis
×
" clinical trials "
×
medicines
×
" boston blog main "
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
6 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines